# PLA2G2D

## Overview
The PLA2G2D gene encodes the enzyme phospholipase A2 group IID, a member of the secretory phospholipase A2 (sPLA2) family, which is involved in lipid metabolism and immune regulation. This enzyme is primarily expressed in immune cells, such as dendritic cells and macrophages, and plays a crucial role in hydrolyzing phospholipids to release bioactive lipids like arachidonic acid and docosahexaenoic acid (DHA) (Murakami2016The; Murakami2019Group). These lipids serve as precursors for anti-inflammatory mediators, contributing to the resolution of inflammation and the maintenance of immune homeostasis (Vijay2015Critical). PLA2G2D is particularly active in secondary lymphoid organs, where it modulates adaptive immune responses by influencing T cell activity and promoting the differentiation of regulatory T cells (Murakami2016The; von2009Secretory). The enzyme's interactions with cell surface receptors and signaling pathways underscore its potential therapeutic implications in inflammatory and autoimmune diseases (von2009Secretory).

## Structure


## Function
The PLA2G2D gene encodes the phospholipase A2 group IID enzyme, which plays a significant role in lipid metabolism and immune regulation. This enzyme is primarily expressed in immune cells, such as dendritic cells and macrophages, and is involved in hydrolyzing phospholipids to release arachidonic acid and docosahexaenoic acid (DHA), which are precursors for various lipid mediators (Murakami2016The; Murakami2019Group). PLA2G2D is particularly active in secondary lymphoid organs, including the spleen and lymph nodes, where it contributes to the modulation of adaptive immune responses (Murakami2016The).

In healthy human cells, PLA2G2D is involved in the production of anti-inflammatory lipid mediators, such as resolvins and protectins, which help resolve inflammation and maintain immune homeostasis (Vijay2015Critical). The enzyme's activity is crucial for dampening Th1-driven adaptive immunity by mobilizing ω3 PUFA-derived resolvins, which suppress dendritic cell migration and antigen presentation to T cells (Murakami2016The). PLA2G2D also plays a role in inhibiting T cell proliferation, promoting the differentiation of regulatory T cells, and modulating immune responses through mechanisms that may involve binding to specific cell surface receptors (von2009Secretory).

## Clinical Significance
Alterations in the expression of the PLA2G2D gene have been associated with various diseases and conditions, particularly those involving immune regulation and inflammation. In the context of cervical squamous cell carcinoma (CSCC), high expression of PLA2G2D is linked to increased immune cell infiltration, including CD8+ T cells, which correlates with better prognosis and patient survival. This suggests that PLA2G2D could serve as a prognostic biomarker in CSCC, influencing the efficacy of immunotherapy strategies such as immune checkpoint inhibitors (Liu2021Metabolic).

In inflammatory conditions, PLA2G2D plays a role in modulating immune responses. Its expression decreases after dendritic cell activation, and deficiency in PLA2G2D can lead to delayed resolution of inflammation, as observed in Th1-dependent contact hypersensitivity models. This indicates its involvement in mobilizing anti-inflammatory lipid mediators (Murakami2016The). Additionally, increased expression of PLA2G2D in the lungs with age contributes to worse outcomes in viral infections like SARS-CoV and influenza, suggesting that its inhibition could potentially restore immune function in older patients (Murakami2016The). These findings highlight the gene's complex role in both promoting and resolving inflammation, depending on the context.

## Interactions
PLA2G2D, or phospholipase A2 group IID, is known to interact with various molecules, influencing immune responses. It is secreted by CD4+CD25+Foxp3+ regulatory T cells (Tregs) and plays a role in inhibiting T cell proliferation through mechanisms that are independent of its catalytic activity, suggesting the involvement of a specific surface receptor. Although the exact receptor remains unidentified, PLA2G2D has been shown to bind strongly to heparan sulfate proteoglycans (HSPGs) on the cell surface, which can be blocked by heparin, indicating a potential interaction with HSPGs in vivo (von2009Secretory).

PLA2G2D also affects the PI3K/Akt/mTOR signaling pathway, inhibiting this pathway and promoting the differentiation of Tregs, which suggests interactions with signaling molecules involved in this pathway (von2009Secretory). Despite its structural similarity to sPLA2-IIA, PLA2G2D does not bind to the M-type receptor, which is known to bind other sPLA2 isoforms (von2009Secretory). These interactions highlight PLA2G2D's role in modulating immune responses and its potential therapeutic implications in inflammatory and autoimmune conditions.


## References


[1. (Murakami2016The) M. Murakami, K. Yamamoto, Y. Miki, R. Murase, H. Sato, and Y. Taketomi. The Roles of the Secreted Phospholipase A2 Gene Family in Immunology, pages 91–134. Elsevier, 2016. URL: http://dx.doi.org/10.1016/bs.ai.2016.05.001, doi:10.1016/bs.ai.2016.05.001. This article has 62 citations.](https://doi.org/10.1016/bs.ai.2016.05.001)

[2. (Liu2021Metabolic) Hong Liu, Ruiyi Xu, Chun Gao, Tong Zhu, Liting Liu, Yifan Yang, Haihong Zeng, Yafei Huang, and Hui Wang. Metabolic molecule pla2g2d is a potential prognostic biomarker correlating with immune cell infiltration and the expression of immune checkpoint genes in cervical squamous cell carcinoma. Frontiers in Oncology, October 2021. URL: http://dx.doi.org/10.3389/fonc.2021.755668, doi:10.3389/fonc.2021.755668. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2021.755668)

[3. (Murakami2019Group) Makoto Murakami, Yoshimi Miki, Hiroyasu Sato, Remi Murase, Yoshitaka Taketomi, and Kei Yamamoto. Group iid, iie, iif and iii secreted phospholipase a2s. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1864(6):803–818, June 2019. URL: http://dx.doi.org/10.1016/j.bbalip.2018.08.014, doi:10.1016/j.bbalip.2018.08.014. This article has 19 citations.](https://doi.org/10.1016/j.bbalip.2018.08.014)

[4. (von2009Secretory) Caroline E. von Allmen, Nicole Schmitz, Monika Bauer, Heather J. Hinton, Michael O. Kurrer, Regula B. Buser, Myriam Gwerder, Simone Muntwiler, Tim Sparwasser, Roger R. Beerli, and Martin F. Bachmann. Secretory phospholipase a2-iid is an effector molecule of cd4+cd25+regulatory t cells. Proceedings of the National Academy of Sciences, 106(28):11673–11678, July 2009. URL: http://dx.doi.org/10.1073/pnas.0812569106, doi:10.1073/pnas.0812569106. This article has 50 citations.](https://doi.org/10.1073/pnas.0812569106)

[5. (Vijay2015Critical) Rahul Vijay, Xiaoyang Hua, David K. Meyerholz, Yoshimi Miki, Kei Yamamoto, Michael Gelb, Makoto Murakami, and Stanley Perlman. Critical role of phospholipase a2 group iid in age-related susceptibility to severe acute respiratory syndrome–cov infection. Journal of Experimental Medicine, 212(11):1851–1868, September 2015. URL: http://dx.doi.org/10.1084/jem.20150632, doi:10.1084/jem.20150632. This article has 115 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1084/jem.20150632)